title: [Efficacy of aphobazole in the treatment of anxiety disorders in patients with chronic cerebro-vascular insufficiency].
authors.forename: I I
authors.initials: II
authors.lastname: Sholomov
authors.forename: E B
authors.initials: EB
authors.lastname: Lutoshkina
authors.forename: E A
authors.initials: EA
authors.lastname: Salina
mesh_terms: D000368:Aged; D014151:Anti-Anxiety Agents / Q000627:therapeutic use*; D001008:Anxiety Disorders / Q000188:drug therapy* / Q000453:epidemiology*; D001562:Benzimidazoles / Q000627:therapeutic use*; D002545:Brain Ischemia / Q000453:epidemiology*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009025:Morpholines / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: C410924:2-((2-morpholino)ethylthio)-5-ethoxybenzimidazole; D014151:Anti-Anxiety Agents; D001562:Benzimidazoles; D009025:Morpholines